KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Change in Inventory: 2020-2023

Historic Change in Inventory for Ginkgo Bioworks Holdings (DNA) over the last 2 years, with Jun 2023 value amounting to -$694,000.

  • Ginkgo Bioworks Holdings' Change in Inventory fell 16.64% to -$694,000 in Q2 2023 from the same period last year, while for Jun 2023 it was -$7.5 million, marking a year-over-year decrease of 238.38%. This contributed to the annual value of -$164,000 for FY2022, which is 126.20% down from last year.
  • According to the latest figures from Q2 2023, Ginkgo Bioworks Holdings' Change in Inventory is -$694,000, which was up 62.59% from -$1.9 million recorded in Q1 2023.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Change in Inventory peaked at $5.3 million during Q1 2022, and registered a low of -$2.7 million during Q4 2022.
  • Moreover, its 3-year median value for Change in Inventory was -$644,500 (2022), whereas its average is -$208,700.
  • The largest annual percentage gain for Ginkgo Bioworks Holdings' Change in Inventory in the last 5 years was 683.41% (2022), contrasted with its biggest fall of 2,276.79% (2022).
  • Ginkgo Bioworks Holdings' Change in Inventory (Quarterly) stood at $1.9 million in 2020, then plummeted by 105.84% to -$112,000 in 2021, then slumped by 2,276.79% to -$2.7 million in 2022, then declined by 16.64% to -$694,000 in 2023.
  • Its Change in Inventory was -$694,000 in Q2 2023, compared to -$1.9 million in Q1 2023 and -$2.7 million in Q4 2022.